CN Patent

CN114340655A — 生产包含glp-1肽的片剂的方法

Assigned to Novo Nordisk AS · Expires 2022-04-12 · 4y expired

What this patent protects

本发明涉及生产包含GLP‑1肽的片剂的方法，其中所述GLP‑1肽通过喷雾干燥包含该GLP‑1肽和进料溶液溶剂的进料溶液而获得，其中该进料溶液的pH高于该GLP‑1肽的pI，或者其中该进料溶液的pH在约5至约10的范围内。本发明还涉及通过所述方法获得的片剂以及所述片剂在医学中的用途。

USPTO Abstract

本发明涉及生产包含GLP‑1肽的片剂的方法，其中所述GLP‑1肽通过喷雾干燥包含该GLP‑1肽和进料溶液溶剂的进料溶液而获得，其中该进料溶液的pH高于该GLP‑1肽的pI，或者其中该进料溶液的pH在约5至约10的范围内。本发明还涉及通过所述方法获得的片剂以及所述片剂在医学中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN114340655A
Jurisdiction
CN
Classification
—
Expires
2022-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.